Lumax 740 ICD range receives FDA approval
Published date : 21 May 2012
Article date : 21 May 2012
The Lumax 740 ICD portfolio from Biotronik has recently received approval from the U.S. Food and Drug Administration (FDA). The Lumax 740 range of implantable cardioverter defibrillators incorporates a range of device design features to help clinicians monitor patients, and is indicated as safe to undergo MRI scans in certain conditions. Lumax 740 ICD devices have already been approved by European regulators (November 2011).
Find out more about the Lumax 740 ICD here.
